for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
Medtech Insight
   Full-text available via subscription Subscription journal
     ISSN (Print) 1876-8008
     Published by Informa plc Homepage  [13 journals]
  • Arrhythmia Monitoring: The Challenges Of Detecting AF In Cryptogenic
    • Abstract: Innovation in arrhythmia monitoring technologies, as well as new research showing how these devices may improve arrhythmia diagnosis and management, particularly in cryptogenic stroke patients, will help drive growth in the market for outpatient ambulatory cardiac monitoring devices, which is valued at approximately $1.5 billion in the US alone.
      PubDate: Fri, 30 May 2014 00:05:15 -040
  • Growth Ahead For US Ophthalmic Surgery Systems Market
    • Abstract: According to a recent Medtech Insight report, the US market for ophthalmic surgical systems totaled almost $1.7 billion in 2013, and is expected to experience healthy – if moderate – growth over the next five years, reaching an estimated $2.26 billion by 2018.
      PubDate: Fri, 30 May 2014 00:05:10 -040
  • Can Pencil Beam Proton Therapy Revolutionize Cancer Care'
    • Abstract: In the billion dollar market for radiotherapy products, pencil beam proton therapy could potentially revolutionize cancer care but the technology is very expensive, and it remains to be seen how many medical institutions in the US and worldwide will be interested in adopting the large systems, which require years to construct. Scripps Proton Therapy Center medical director Carl Rossi, MD, speaks about the benefits of proton therapy compared with other types of radiation therapy.
      PubDate: Fri, 30 May 2014 00:05:06 -040
  • Mega-Deals In Orthopedics: Size Matters
    • Abstract: With the surprise announcement that Zimmer, the number three player, will acquire Biomet, the number five player, in a transaction valued at $13 billion, a transformation in the orthopedic industry is underway. Most of the major orthopedic manufacturers are primed with a war chest of cash to make acquisitions for future growth, and as health care reform unfolds, companies are positioning themselves to compete in a changing world where “bigger is better.”
      PubDate: Fri, 30 May 2014 00:05:02 -040
  • Silk Road Medical Inc.
    • Abstract: Patients with carotid artery disease currently have two treatment options: traditional surgical repair or transfemoral stenting, but a new minimally invasive therapy that combines the benefits and minimizes the shortcomings of these two choices will soon be available. The ENROUTE procedure from Silk Road Medical consists of a neuroprotection system that reverses blood flow out of the brain to protect the brain from any debris that is liberated during the procedure, and a permanent stent that props open the narrowed carotid artery.
      PubDate: Fri, 30 May 2014 00:01:58 -040
  • FDA Clear’s Monarch Medical’s Glycemic Control Technology
    • Abstract: Monarch Medical Technologies has received FDA clearance for its EndoTool IV glucose management solution, part of the previously released EndoTool Glucose Management System platform.
      PubDate: Fri, 30 May 2014 00:01:53 -040
  • Self-Expanding Sinus Dilation Technology Offers More With Less
    • Abstract: SinuSys Corp. received FDA clearance in December 2013 for its Vent-Os Sinus Dilation System, a novel in-office treatment for patients with chronic rhinosinusitis (CRS) affecting the maxillary sinus that uses a self-expanding, removable capsule and osmotic technology to open the sinuses
      PubDate: Fri, 30 May 2014 00:01:49 -040
  • HRS 2014 Roundup
    • Abstract: The 2014 Heart Rhythm Society Scientific Sessions ended May 10 in San Francisco with a big study from Boston Scientific on the benefits of implantable cardioverter defibrillator remote monitoring, and data on a smartphone-enabled electrocardiogram and the use of a spinal stimulator for heart failure patients. Earlier in the meeting, data were reported on the success of pacemaker remote monitoring and other studies.
      PubDate: Fri, 30 May 2014 00:01:36 -040
  • Ergoresearch Handheld Scanner Replaces Plaster Cast For Fitting Knee Brace
    • Abstract: Canadan-based Ergoresearch Ltd. has developed a 360-degree scanning system to create custom-fit knee orthotics.
      PubDate: Fri, 30 May 2014 00:01:33 -040
  • EuroPCR: Edwards' Sapien 3 Could Be Game Changer
    • Abstract: Post-litigation settlement, Edwards Lifesciences is again facing competition from arch TAVI rival Medtronic, but it’s third-generation Sapien 3 device could save the day. Edwards presented late-breaking data from the SAPIEN 3 trial at the EuroPCR meeting, held in Paris in May.
      PubDate: Fri, 30 May 2014 00:01:29 -040
  • TurboTax For 510(k)s' FDA Seeks Volunteers For eSubmissions Pilot
    • Abstract: The agency has launched a pilot that will allow makers of cardiac diagnostic and peripheral interventional devices to submit 510(k)s in electronic-only format. FDA says it expects the program to improve both speed and quality of submissions.
      PubDate: Fri, 30 May 2014 00:01:22 -040
  • Healthcare IT Discussion Stresses Local Implementation, Legislation
    • Abstract: Government officials and the health IT world met for three days last week to discuss future regulation. The talk focused on the best way to oversee software after it has been installed, implemented, and customized, as well as the potential need for legislation to define the regulatory field.
      PubDate: Fri, 30 May 2014 00:01:17 -040
  • EmboMedics Inc.
    • Abstract: EmboMedics Inc. has developed a bioresorbable embolic bead technology to treat uterine fibroids without causing long-term side effects. Currently in preclinical testing, EmboMedics' technology will initially be used in the treatment of uterine fibroids, although its potential for controlled and predictable drug release could lend itself to a variety of other acute and chronic indications, including liver and prostate cancer, trauma, and obesity.
      PubDate: Fri, 30 May 2014 00:01:12 -040
  • HeadSense Medical Ltd.
    • Abstract: Drilling a burr hole in the skull and placing a pressure sensor in the brain tissue is the unsettling but standard method for monitoring intracranial pressure in patients with severe traumatic brain injury or stroke. HeadSense Medical Ltd. has developed a noninvasive patient headset and tablet monitor that uses a low-frequency acoustic signal to automatically and continuously measure ICP.
      PubDate: Fri, 30 May 2014 00:01:09 -040
  • Medtech Execs On The Move, May 2014
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Fri, 30 May 2014 00:00:55 -040
  • Medical Device Deals Update, May 2014
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced April-May 2014.
      PubDate: Fri, 30 May 2014 00:00:46 -040
  • Robust Growth Forecast For European Spinal Disc Market
    • Abstract: According to a recent Medtech Insight report, the European market for artificial spinal discs totaled approximately $145 million in 2012. During the forecast period covered by the report, the combined market is projected to increase at a compound annual rate of 9.2%.
      PubDate: Wed, 30 Apr 2014 00:05:22 -040
  • Stroke Devices: Neurointerventional Solutions Offer Promise In Treatment
           And Prevention
    • Abstract: At this year’s International Stroke Conference, manufacturers offered a glimpse of new and emerging technologies for both ischemic and hemorrhagic stroke. These neurointerventional devices are gaining momentum and driving growth in the market for stroke products, a largely un-penetrated market valued at more than $1 billion worldwide.
      PubDate: Wed, 30 Apr 2014 00:05:15 -040
  • Renal Denervation: Stepping Back To Move Forward
    • Abstract: With the announcement that Medtronic is going back to the clinical drawing board after the pivotal SYMPLICITY HTN-3 trial of its renal denervation device failed to meet its primary efficacy endpoint, the industry is taking a cautious but still optimistic stance on the highly touted potential treatment for resistant hypertension.
      PubDate: Wed, 30 Apr 2014 00:05:12 -040
  • Efforts Accelerate To Add Unique Device IDs To Insurance Claims
    • Abstract: Groups are mobilizing now to ensure that UDIs for high risk implantable devices are incorporated into claims, although it will likely be several years at least before that becomes a reality. The goal is to facilitate better data collection and more effective product recalls.
      PubDate: Wed, 30 Apr 2014 00:01:38 -040
  • Xeltis AG: Spontaneous Natural Tissue Growth For Heart Valve Replacement
    • Abstract: Rather than relying on an animal or cadaver implant to repair severe congenital heart malformations, Xeltis AG has developed a synthetic and biodegradable replacement pulmonary valve, designed to stimulate and guide the body’s natural healing response. The company’s technology, which has opened up an entirely new therapeutic category called endogenous tissue growth, is designed to provide a single intervention that can last for a lifetime.
      PubDate: Wed, 30 Apr 2014 00:01:34 -040
  • EBS Technologies: Stimulating “Silent Neurons” To Restore
           Impaired Vision
    • Abstract: EBS Technologies GMBH is shattering the current paradigm that once a person loses sight it cannot be regained. Its NEXT WAVE repetitive retinofugal alternate current stimulation technology uses noninvasive electrical stimulation to reactivate networks of “silent neurons” in patients with ophthalmic diseases or who have lost vision following brain injury.
      PubDate: Wed, 30 Apr 2014 00:01:27 -040
  • Report: Unmet Need Can Trump Modest Data In Quest For Reimbursement
    • Abstract: A higher level of evidence did not correlate well with subsequent payor reimbursement, according to a comparison of the coverage success for devices approved via HDE and PMA conducted by Avalere Health for the Pew Charitable Trusts. Perceptions of unmet need tended to serve a bigger factor for coverage, the report said.
      PubDate: Wed, 30 Apr 2014 00:01:23 -040
  • CoolCore Biomedical Technologies: Manipulating Body Core Temperature
    • Abstract: Similar to holding a lighted match near a thermostat to induce a lower room temperature, CoolCore Biomedical Technologies LLC’s technology cools the body by tricking it into thinking it is hotter than it actually is. According to its founders, SmartCool is the only totally noninvasive effective cooling technology designed to prevent or limit reperfusion injury (brain and tissue damage) within the critical initial time frame following an ischemic event such as sudden cardiac arrest, stroke, or traumatic brain injury.
      PubDate: Wed, 30 Apr 2014 00:01:19 -040
  • Somersault Orthopedics: Surgical Planning For Joint Replacement
    • Abstract: Somersault Orthopedics Inc.’s enhanced surgical planning software for joint replacement procedures is designed to increase orthopedic surgeons’ efficiency and accuracy when using patient-specific instrumentation, thus resulting in better patient outcomes.
      PubDate: Wed, 30 Apr 2014 00:01:15 -040
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014